New pill aims to tame eye inflammation without infection

NCT ID NCT07552012

Recruiting now Disease control Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. Source: ClinicalTrials.gov ↗

First seen Apr 28, 2026 · Last updated May 20, 2026 · Updated 4 times

Summary

This study tests an experimental tablet called FXS5626 in 40 adults with active non-infectious uveitis, a condition causing swelling inside the eye. The goal is to see if the drug can control inflammation and prevent worsening of the disease compared to a placebo. Participants will take the tablet or placebo daily for 24 weeks, and doctors will monitor their eye health and any side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACTIVE NON-ANTERIOR NON-INFECTIOUS UVEITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

EC of the First Affiliated Hospital of Chongqing Medical University
RECRUITING

Chongqing, Chongqing Municipality, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ACTIVE NON-ANTERIOR NON-INFECTIOUS UVEITIS